COMPANY PROFILE // THE 014 REPORT
Repare Therapeutics Inc.
Assembled from 2 government sources in 0.2 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
- Amber8-K Item 3.01 filed: notice of delisting, of a failed continued-listing rule, or of a transfer of listing on 2026-01-28 (last 24 months).
✓ SEC filings✗ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no state registration, no website, no lobbying registration on record.
Repare Therapeutics Inc. is an SEC-registered operating company in pharmaceutical preparations, incorporated in Canada (federal), based in Saint-Laurent, Quebec, Canada.[source] It has filed 31 documents with the SEC in the last 12 months; the latest is a SCHEDULE 13G/A, filed 2026-05-14.[source] Seraphix flags 1 item from these records: 8-K Item 3.01 filed.[source]
- red0
- amber1
- info0
- CLEAR26
- POSSIBLE MATCH0
- MATCH0
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0001808158 | source |
| EIN | 00-0000000 | source |
| Business address (SEC) | 7171 FREDERICK BANTING, SUITE 270, BUILDING 2, SAINT-LAURENT, A8, H4S 1Z9 | source |
Does not exist in the records we hold: LEI, UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-03-31 · in 129 days · Next 10-K due (period ended 2026-12-31; Non-accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
- 2027-05-15 · in 174 days · Next 10-Q due (period ended 2027-03-31; Non-accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 2834 (pharmaceutical preparations): 568 companies in our records share this code.
Peers, each with its 014
- PFIZER INC · 124 SEC filings in 12 months · $25.74B federal (possible match)
- Merck & Co., Inc. · 150 SEC filings in 12 months · $13.51B federal (possible match)
- ABBOTT LABORATORIES · 118 SEC filings in 12 months · 1 flag · $2.64B federal (possible match)
- ASTRAZENECA PLC · 140 SEC filings in 12 months · $602.8M federal (possible match)
- TEVA PHARMACEUTICAL INDUSTRIES LTD · 168 SEC filings in 12 months · $77.6M federal (possible match)
- NOVARTIS AG · 34 SEC filings in 12 months · $41.9M federal (possible match)
- Spero Therapeutics, Inc. · 41 SEC filings in 12 months · 4 flags · $39.5M federal (possible match)
- Grifols SA · 18 SEC filings in 12 months · $22.5M federal (possible match)
- SCYNEXIS INC · 54 SEC filings in 12 months · 3 flags · $18.5M federal (possible match)
- Ensysce Biosciences, Inc. · 45 SEC filings in 12 months · 3 flags · $15.1M federal (possible match)
- UNITED THERAPEUTICS Corp · 454 SEC filings in 12 months · 2 flags · $6.8M federal (possible match)
- Zoetis Inc. · 144 SEC filings in 12 months · 1 flag · $6.7M federal (possible match)
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-02-19 filing 15-12G · SEC EDGAR
- 2026-01-30 filing EFFECT · SEC EDGAR
- 2026-01-30 filing SCHEDULE 13D/A · SEC EDGAR
- 2026-01-28 filing S-8 POS · SEC EDGAR
- 2026-01-28 filing S-8 POS · SEC EDGAR
- 2026-01-28 filing S-8 POS · SEC EDGAR
- 2026-01-28 filing S-8 POS · SEC EDGAR
- 2026-01-28 filing S-8 POS · SEC EDGAR
- 2026-01-28 filing S-8 POS · SEC EDGAR
- 2026-01-28 filing S-8 POS · SEC EDGAR
- 2026-01-28 filing S-8 POS · SEC EDGAR
- 2026-01-28 filing POS AM · SEC EDGAR
- 2026-01-28 officer change 8-K items 2.01,3.01,3.03,5.01,5.02,8.01,9.01 · SEC EDGAR
- 2026-01-28 filing 25-NSE · SEC EDGAR
- 2026-01-16 filing 8-K items 5.07,7.01,9.01 · SEC EDGAR
- 2025-12-29 filing DEFA14A · SEC EDGAR
- 2025-12-29 filing 8-K items 1.01,2.01,7.01,8.01,9.01 · SEC EDGAR
- 2025-12-19 filing DEFA14A · SEC EDGAR
- 2025-12-19 officer change 8-K items 5.02 · SEC EDGAR
- 2025-12-15 filing DEFM14A · SEC EDGAR
- 2025-12-15 filing DEFA14A · SEC EDGAR
- 2025-12-03 filing PREM14A · SEC EDGAR
- 2025-11-24 filing SCHEDULE 13D/A · SEC EDGAR
- 2025-11-21 filing SCHEDULE 13D/A · SEC EDGAR
- 2025-11-20 filing DEFA14A · SEC EDGAR
- 2025-11-17 filing DEFA14A · SEC EDGAR
- 2025-11-17 filing 8-K items 1.01,9.01 · SEC EDGAR
- 2025-11-14 filing Quarterly report (10-Q) · SEC EDGAR
- 2025-11-14 filing DEFA14A · SEC EDGAR
- 2025-11-14 filing 8-K items 2.02,8.01,9.01 · SEC EDGAR
141 earlier entries
- 2025-10-22 filing 8-K items 7.01
- 2025-08-08 filing Quarterly report (10-Q)
- 2025-08-08 filing 8-K items 2.02,9.01
- 2025-07-16 filing 8-K items 1.01,7.01,9.01
- 2025-06-20 officer change 8-K items 5.02
- 2025-06-17 filing 8-K items 5.07
- 2025-06-02 officer change 8-K/A items 5.02
- 2025-05-13 filing Quarterly report (10-Q)
- 2025-05-13 filing 8-K items 2.02
- 2025-05-01 filing 8-K items 7.01,9.01
- 2025-04-29 filing ARS
- 2025-04-29 filing DEFA14A
- 2025-04-29 filing Proxy statement
- 2025-03-31 officer change 8-K items 5.02,7.01,9.01
- 2025-03-03 filing S-8
- 2025-03-03 filing Annual report (10-K)
- 2025-03-03 filing 8-K items 2.02,9.01
- 2025-02-25 officer change 8-K items 2.05,5.02
- 2025-01-31 filing SCHEDULE 13D/A
- 2025-01-15 filing SCHEDULE 13D/A
- 2025-01-10 filing 8-K items 2.02,7.01,9.01
- 2025-01-06 filing SCHEDULE 13D/A
- 2024-12-26 filing SCHEDULE 13D/A
- 2024-12-12 filing 8-K items 7.01,8.01,9.01
- 2024-11-07 filing 424B5
- 2024-11-07 filing Quarterly report (10-Q)
- 2024-11-07 filing 8-K items 2.02,9.01
- 2024-08-28 filing 8-K items 2.05,7.01,8.01,9.01
- 2024-08-19 filing EFFECT
- 2024-08-15 filing CORRESP
- 2024-08-08 filing UPLOAD
- 2024-08-07 officer change 8-K items 5.02
- 2024-08-06 filing S-3
- 2024-08-06 filing Quarterly report (10-Q)
- 2024-08-06 filing 8-K items 2.02,9.01
- 2024-06-17 filing 8-K items 5.07
- 2024-05-24 filing S-8
- 2024-05-07 filing Quarterly report (10-Q)
- 2024-05-07 filing 8-K items 2.02,9.01
- 2024-04-26 officer change 8-K items 5.02,7.01,9.01
- 2024-04-26 filing ARS
- 2024-04-26 filing DEFA14A
- 2024-04-26 filing Proxy statement
- 2024-03-27 filing 144
- 2024-03-26 filing 144
- 2024-03-25 filing 144
- 2024-03-25 filing 144
- 2024-03-25 filing 144
- 2024-02-28 filing S-8
- 2024-02-28 filing Annual report (10-K)
- 2024-02-28 filing 8-K items 2.02,9.01
- 2024-02-12 filing 8-K items 1.02,8.01,9.01
- 2024-01-25 filing 8-K items 8.01,9.01
- 2024-01-12 filing 8-K items 8.01,9.01
- 2023-11-17 filing SC 13D/A
- 2023-11-15 filing 8-K items 7.01,8.01,9.01
- 2023-11-09 filing Quarterly report (10-Q)
- 2023-11-09 filing 8-K items 2.02,9.01
- 2023-11-03 filing SC 13D
- 2023-10-13 filing 8-K items 7.01,9.01
- 2023-10-13 filing 8-K items 7.01,8.01,9.01
- 2023-10-06 filing 8-K items 7.01
- 2023-08-09 filing Quarterly report (10-Q)
- 2023-08-09 filing 8-K items 2.02,9.01
- 2023-06-09 filing 8-K items 5.07
- 2023-06-07 filing 8-K items 8.01,9.01
- 2023-06-06 filing 144
- 2023-05-30 filing S-8
- 2023-05-10 filing 144
- 2023-05-09 filing Quarterly report (10-Q)
- 2023-05-09 filing 8-K items 2.02,9.01
- 2023-04-28 officer change 8-K items 5.02,7.01,9.01
- 2023-04-28 filing ARS
- 2023-04-28 filing DEFA14A
- 2023-04-28 filing Proxy statement
- 2023-04-18 filing 8-K items 7.01,9.01
- 2023-03-10 filing 8-K items 8.01
- 2023-03-01 filing S-8
- 2023-02-28 filing Annual report (10-K)
- 2023-02-28 filing 8-K items 2.02,9.01
- 2023-01-06 filing SC 13D/A
- 2022-11-09 filing Quarterly report (10-Q)
- 2022-11-09 filing 8-K items 2.02,9.01
- 2022-08-04 filing 424B5
- 2022-08-04 filing Quarterly report (10-Q)
- 2022-08-04 filing 8-K items 2.02,9.01
- 2022-06-13 filing SC 13D/A
- 2022-06-01 filing 8-K items 1.01,7.01,9.01
- 2022-05-16 officer change 8-K items 5.02,5.07
- 2022-05-05 filing Quarterly report (10-Q)
- 2022-05-05 filing 8-K items 2.02,9.01
- 2022-04-25 filing EFFECT
- 2022-04-01 filing DEFA14A
- 2022-04-01 filing Proxy statement
- 2022-03-11 filing S-8
- 2022-03-07 filing POS AM
- 2022-03-02 filing POS AM
- 2022-03-01 filing Annual report (10-K)
- 2022-03-01 filing 8-K items 2.02,9.01
- 2022-03-01 filing POSASR
- 2022-01-10 filing 8-K items 2.02
- 2022-01-07 filing 8-K items 7.01,9.01
- 2021-11-10 filing Quarterly report (10-Q)
- 2021-11-10 filing 8-K items 2.02,9.01
- 2021-11-02 filing SC 13D/A
- 2021-11-01 filing 8-K items 1.01,8.01,9.01
- 2021-10-28 filing 424B5
- 2021-10-27 filing 424B5
- 2021-10-08 filing 8-K items 7.01,9.01
- 2021-09-08 officer change 8-K items 5.02,7.01,9.01
- 2021-08-16 filing SC 13D/A
- 2021-08-12 filing 8-K items 2.02,9.01
- 2021-08-12 filing Quarterly report (10-Q)
- 2021-07-21 filing SC 13D/A
- 2021-07-02 filing S-3ASR
- 2021-05-25 filing SC 13D/A
- 2021-05-14 filing 8-K items 5.07
- 2021-05-13 filing Quarterly report (10-Q)
- 2021-05-13 filing 8-K items 2.02,9.01
- 2021-04-08 filing 8-K items 7.01,8.01,9.01
- 2021-04-06 filing S-8
- 2021-04-01 filing DEFA14A
- 2021-04-01 filing Proxy statement
- 2021-03-23 filing SC 13D/A
- 2021-03-04 filing Annual report (10-K)
- 2021-03-04 filing 8-K items 2.02,9.01
- 2021-02-26 filing SC 13D/A
- 2021-01-25 filing SC 13D/A
- 2020-11-12 filing Quarterly report (10-Q)
- 2020-11-12 filing 8-K items 2.02,9.01
- 2020-08-13 filing Quarterly report (10-Q)
- 2020-08-13 filing 8-K items 2.02,9.01
- 2020-07-07 filing SC 13D
- 2020-07-06 filing 3/A
- 2020-07-06 filing SC 13D
- 2020-06-26 filing SC 13D
- 2020-06-24 filing S-8
- 2020-06-23 filing 8-K items 5.03,8.01,9.01
- 2020-06-19 filing 424B4
- 2020-06-19 filing FWP
- 2020-06-18 filing EFFECT
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-02-19 (older) 15-12G filed
- 2026-01-30 (older) EFFECT filed
- 2026-01-28 (older) S-8 POS filed
- 2026-01-28 (older) S-8 POS filed
- 2026-01-28 (older) S-8 POS filed
- 2026-01-28 (older) S-8 POS filed
- 2026-01-28 (older) S-8 POS filed
- 2026-01-28 (older) S-8 POS filed
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-22; the colour is also written out in words.
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- No listing symbol is held for this company.
- Open in
Open in…
Insider trades
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
0 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 1808158 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| CUSIP | 760273102 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001808158 | SEC EDGAR |
The company table did not answer, so only the identifiers carried on the SEC record are shown.
Next: reload in a minute, or open the record page.
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Net income (loss) (fiscal year ended 2024-12-31) | -$84,689,000 | 2024-12-31 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-22 05:03 UTC | Report an error |
| Total assets (at 2024-12-31) | $176,506,000 | 2024-12-31 | 10-K, XBRL Assets | as filed | 2026-11-22 05:03 UTC | Report an error |
| Stockholders' equity (at 2024-12-31) | $151,131,000 | 2024-12-31 | 10-K, XBRL StockholdersEquity | as filed | 2026-11-22 05:03 UTC | Report an error |
| Cash and cash equivalents (at 2024-12-31) | $84,717,000 | 2024-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-22 05:03 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-05-14 | SEC EDGAR company profile | as filed | 2026-11-22 05:03 UTC | Report an error |
| SIC industry | 2834 Pharmaceutical Preparations | 2026-05-14 | SEC EDGAR company profile | as filed | 2026-11-22 05:03 UTC | Report an error |
| State of incorporation | Z4 | 2026-05-14 | SEC EDGAR company profile | as filed | 2026-11-22 05:03 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-05-14 | SEC EDGAR company profile | as filed | 2026-11-22 05:03 UTC | Report an error |
| Business address | 7171 FREDERICK BANTING, SUITE 270, BUILDING 2, SAINT-LAURENT, A8, H4S 1Z9 | 2026-05-14 | SEC EDGAR company profile | as filed | 2026-11-22 05:03 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2024-12-31) | -$76,445,000 | 2024-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-22 05:03 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2024-12-31) | $0 | 2024-12-31 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | as filed | 2026-11-22 05:03 UTC | Report an error |
| Operating lease liabilities (at 2024-12-31) | $1,933,000 | 2024-12-31 | 10-K, XBRL OperatingLeaseLiability | as filed | 2026-11-22 05:03 UTC | Report an error |
Latest report: 10-Q for the period ended 2025-09-30, filed 2025-11-14 · accession 0001193125-25-283336
Old data: the newest 10-Q or 10-K in SEC company facts has no later XBRL values.
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Net income (loss) | $3,258,000 | 3 months ended 2025-09-30 | 10-Q | 2025-11-14 | 0001193125-25-283336 | 2026-11-22 05:03 UTC | Report an error |
| Cash and cash equivalents | $72,825,000 | at 2025-09-30 | 10-Q | 2025-11-14 | 0001193125-25-283336 | 2026-11-22 05:03 UTC | Report an error |
| Contract liabilities, current (from an earlier report) | $0 | at 2024-12-31 | 10-K | 2025-03-03 | 0000950170-25-030405 | 2026-11-22 05:03 UTC | Report an error |
| Contract liabilities, noncurrent (from an earlier report) | $0 | at 2024-12-31 | 10-K | 2025-03-03 | 0000950170-25-030405 | 2026-11-22 05:03 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-02-19 Filing 15-12G filed
- 2026-01-30 Filing EFFECT filed
- 2026-01-28 Filing S-8 POS filed
- 2026-01-28 Filing S-8 POS filed
- 2026-01-28 Filing S-8 POS filed
- 2026-01-28 Filing S-8 POS filed
- 2026-01-28 Filing S-8 POS filed
- 2026-01-28 Filing S-8 POS filed
- 2026-01-28 Filing S-8 POS filed
- 2026-01-28 Filing S-8 POS filed
- 2026-01-28 Filing POS AM filed
- 2026-01-28 Filing 8-K filed: Item 2.01 acquisition or disposition; Item 3.01 delisting notice; Item 3.03 rights of holders modified; Item 5.01 change in control; Item 5.02 officer or director change; Item 8.01 other event; Item 9.01 exhibits
- 2026-01-28 Filing 25-NSE filed
- 2026-01-16 Filing 8-K filed: Item 5.07 shareholder vote; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2025-12-29 Filing DEFA14A filed
- 2025-12-29 Filing 8-K filed: Item 1.01 material agreement; Item 2.01 acquisition or disposition; Item 7.01 Regulation FD disclosure; Item 8.01 other event; Item 9.01 exhibits
- 2025-12-19 Filing DEFA14A filed
- 2025-12-19 Filing 8-K filed: Item 5.02 officer or director change
- 2025-12-15 Filing DEFM14A filed
- 2025-12-15 Filing DEFA14A filed
- 2025-12-03 Filing PREM14A filed
- 2025-11-20 Filing DEFA14A filed
- 2025-11-17 Filing DEFA14A filed
- 2025-11-17 Filing 8-K filed: Item 1.01 material agreement; Item 9.01 exhibits
- 2025-11-14 Filing 10-Q filed
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/1808158.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001808158. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.